PackTalk is a blog for the Healthcare Packaging Industry

Conversations in the Medical Device Industry


Published on February 9, 2021

“By failing to prepare, you are preparing to fail.” - Benjamin Franklin

Benjamin Franklin was right. We must apply lessons learned to current industry action plans. 

For nearly a year, the majority of published content (professional or leisure) has opened with a reference to the COVID-19 pandemic. Has our world developed tunnel vision? Are we normalizing crisis as the driver of all business strategies and operations? While it’s not simple, on consideration, we can answer no to all. However, until the immersion of industry into COVID-19 impacts wanes, we can expect COVID-19 to steer conversations and direct future plans.

This recent article from MD+DI supports the premise that crisis-aware planning is a prudent approachWe concur with the three lessons presented here and believe they serve as effective conversation starters for teams across the medical device and healthcare manufacturing fields. 

We’ll all celebrate the day when COVID-19 mentions disappear. Until then, we can cheer each other on, as we collaboratively work to innovate for the prize of human health and wellbeing. 

 Read More 

 

PHOTO CREDIT: MD+DI


Comments (0)

Related Articles

One Doctor’s Request for Sustainable Change in Asia

September 17, 2021

152 kilograms. 4500 tonnes. 134 hectares. No matter how you say it, it’s not positive or sustainable. These numbers reflect the amount of medical waste from just one surgery, in a study from four hospitals over three months in New Zealand. 152 kilograms is...

Learn More

Cracking the Age Old Dilemma: Compliance or Quality?

September 17, 2021

I recently read an article from Medtech Insights on how device giants Stryker and Baxter embrace a quality first culture – and yield positive results. In the article, Stryker’s Medha Trivedi, the company’s senior director of global quality and operations said...

Learn More

Power to the PDUFA

September 17, 2021

The Prescription Drug User Fee Act was passed into law by Congress in 1992. The PDUFA implemented a fee-based framework for New Drug Applications and Biologics License Applications. One of its primary objectives was to provide funding to speed up the glacial...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.